RICT 2016

Interfacing Chemical Biology and Drug Discovery

52nd International Conference on Medicinal Chemistry
52èmes Rencontres Internationales de Chimie Thérapeutique

 Caen, Normandy, France    July 6-8, 2016

Committees


Executive Scientific Committee

Members

Dr M. BALTAS

CNRS, University of Toulouse, Toulouse, France

Prof. R. BUREAU

University of Caen, Caen, France

Prof. P. DALLEMAGNE

University of Caen, Caen, France

Dr P. GEORGE

SCT & Independent Scientific Expert & Adviser, Longvilliers, France

Prof. B. LINCLAU

University of Southampton, Southampton, United Kingdom

Prof. C. ROCHAIS

University of Caen, Caen, France

Prof. J. SAPI

SCT & University of Reims-Champagne-Ardenne, Reims, France

Dr L. VAN HIJFTE

SCT & NovAliX, Nijmegen, The Netherlands

Prof. A. S. VOISIN-CHIRET

University of Caen, Caen, France

Local Organising Committee

Members

Prof. R. BUREAU

University of Caen, Caen, France

Prof. V. COLLOT

University of Caen, Caen, France

Prof. P. DALLEMAGNE

University of Caen, Caen, France

Prof. F. FABIS

University of Caen, Caen, France

Prof. A. MALZERT-FREON

Unversity of Caen, Caen, France

Prof. C. ROCHAIS

University of Caen, Caen, France

Prof. A. S. VOISIN-CHIRET

University of Caen, Caen, France

Scientific Advisory Board

Members

Dr F. ACHER

CNRS - University Paris Descartes, Paris, France

Dr K.-H. BARINGHAUS

Sanofi, Frankfurt, Germany

Prof. J. BOCKAERT

University of Montpellier, Montpellier, France

Prof. M. L. BOLOGNESI

University of Bologna, Bologna, Italy

Prof. P. BONNET

University of Orléans, Orléans, France

Dr A. BROWN

Stratified Medical, Deal, United Kingdom

Dr M. CASES-THOMAS

Eli Lilly & Company, United Kingdom

Mr J.-D. CHARRIER

Vertex Pharmaceuticals, OXON, United Kingdom

Dr J. CHRISTOPHER

Heptares, Hertfordshire, United Kingdom

Dr I. DORANGE

DOMAIN THERAPEUTICS, ILLKIRCH, France

Dr C. GARCIA-ECHEVERRIA

Sanofi, Vitry sur Seine, France

Dr J. GRACIA

Almirall, Barcelona, Spain

Prof. Y. HASHIMOTO

The University of Tokyo, Tokyo, Japan

Prof. J. HASSERODT

ENS, Lyon, France

Prof. M. HIBERT

University of Strasbourg, Illkirch, France

Dr L. LINUS

Eli Lilly & Company, Shanghai, China

Dr G. J. MACDONALD

Janssen Research & Development, Beerse, Belgium

Dr F. MARSAIS

VFP Therapies, Rouen, France

Dr D. MEIBOM

Bayer Pharma, Wuppertal, Germany

Dr C. MENET

Confo Therapeutics, Brussels, Belgium

Dr A. T. PLOWRIGHT

AstraZeneca, Frankfurt-Am-Main, Germany

Dr R. PRUSS

Trophos SA, Marseille Cedex 9, France

Prof. J.-L. REYMOND

SCS DMCCB & University of Bern, Bern, Switzerland

Dr J.-P. ROCHER

Pierre Fabre Research Institute, Toulouse, France

Dr H. UENO

Mitsubishi Tanabe Pharma, Osaka , Japan

Prof. M. UESUGI

Kyoto University, Kyoto, Japan

Dr A. VALADE

UCB, Braine-l'Alleud, Belgium

Dr J. VELCICKY

Novartis Institutes for Biomedical Research, Basel, Switzerland

Dr F. VON NUSSBAUM

Bayer Pharma, Berlin, Germany

Dr J. WAI

WuXi AppTec, Shanghai, China

Prof. M. WARING

University of Newcastle, Newcastle upon Tyne, United Kingdom